Unither Industries

Unither Industries, located in Gannat, France, is a key manufacturing facility and subsidiary of Unither Pharmaceuticals, a global leader in sterile unit-dose contract development and manufacturing (CDMO). Established in 2008 following Unither's acquisition of the Creapharm Gannat site, the facility specializes in the production of sterile Blow-Fill-Seal (BFS) single doses, particularly for physiological saline and rhinology applications. Additionally, Unither Industries manufactures solid and semi-solid pharmaceutical forms, including suppositories, pessaries, and hormone-based vaginal treatments. The site serves as a major industrial hub for the group, supporting both clinical batch preparation and large-scale commercial manufacturing for global pharmaceutical clients. In 2026, the facility embarked on a major €140 million expansion in partnership with Laboratoires Théa to establish a new state-of-the-art ophthalmic production unit.